Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A

被引:29
作者
Anish, Chakkumkal [1 ]
Upadhyay, Arun K. [1 ]
Sehgal, Devinder [1 ]
Panda, Amulya Kumar [1 ]
机构
[1] Natl Inst Immunol, New Delhi 110067, India
关键词
Pneumococcal surface protein A (PspA); Polylactide particles; Powder flow properties; Spray drying; Antibody response; STREPTOCOCCUS-PNEUMONIAE; PLGA MICROPARTICLES; IMMUNE-RESPONSE; ANTIGEN; PSPA; IMMUNIZATION; RELEASE; ANTIBODIES; INFECTION; DELIVERY;
D O I
10.1016/j.ijpharm.2014.03.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Particle size, antigen load and its release characteristic are the three the main attributes of polymer particles based vaccine delivery systems. The present studies focus on the formulation of spray dried polylactide microparticles entrapping pneumococcal surface protein A (PspA). Influence of process variables during polymer particle formation were optimized by using half-factorial design. Feed rate and atomization pressure during spray drying were found to be the most important parameters for achieving uniform size particles. Spray drying of preformed particles from different stages of solvent evaporation method resulted in formation of particle having different porosity and protein release profile. Presence of polyvinyl alcohol in the external aqueous phase not only contributed towards regulating the size of particles but also influenced the burst release of protein from particles. Polymer particles entrapping PspA elicited robust IgG responses both in mice and in rats. Antigen load in microparticles correlated with the antibody titer indicating the maintenance of protein integrity during particle formation using spray drying. Both, process engineering and formulation parameters during spray drying influenced the particles in terms of size, load and antigen release characteristics. (C) 2014 Elsevier B. V. All rights reserved.
引用
收藏
页码:198 / 210
页数:13
相关论文
共 29 条
  • [1] Allison SD, 2008, EXPERT OPIN DRUG DEL, V5, P615, DOI [10.1517/17425247.5.6.615, 10.1517/17425247.5.6.615 ]
  • [2] The immunogenic characteristics associated with multivalent display of Vi polysaccharide antigen using biodegradable polymer particles
    Anish, Chakkumkal
    Goswami, Dinesh G.
    Kanchan, Vibhu
    Mathew, Simi
    Panda, Amulya K.
    [J]. BIOMATERIALS, 2012, 33 (28) : 6843 - 6857
  • [3] Baras B, 2000, J MICROENCAPSUL, V17, P485
  • [4] Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers
    Baras, B
    Benoit, MA
    Poulain-Godefroy, O
    Schacht, AM
    Capron, A
    Gillard, J
    Riveau, G
    [J]. VACCINE, 2000, 18 (15) : 1495 - 1505
  • [5] Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)
    Briles, DE
    Tart, RC
    Swiatlo, E
    Dillard, JP
    Smith, P
    Benton, KA
    Ralph, BA
    Brooks-Walter, A
    Crain, MJ
    Hollingshead, SK
    McDaniel, LS
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) : 645 - +
  • [6] Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
    Briles, DE
    Hollingshead, SK
    King, J
    Swift, A
    Braun, PA
    Park, MK
    Ferguson, LM
    Nahm, MH
    Nabors, GS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1694 - 1701
  • [7] Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice
    Chung Truong Nguyen
    Kim, Soo Young
    Kim, Myoung Suk
    Lee, Shee Eun
    Rhee, Joon Haeng
    [J]. VACCINE, 2011, 29 (34) : 5731 - 5739
  • [8] Modified Opsonization, Phagocytosis, and Killing Assays To Measure Potentially Protective Antibodies against Pneumococcal Surface Protein A
    Daniels, Calvin C.
    Kim, Kyung-Hyo
    Burton, Robert L.
    Mirza, Shaper
    Walker, Melissa
    King, Janice
    Hale, Yvette
    Coan, Patricia
    Rhee, Dong-Kwon
    Nahm, Moon H.
    Briles, David E.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (10) : 1549 - 1558
  • [9] Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen
    De Temmerman, Marie-Luce
    Rejman, Joanna
    Vandenbroucke, Roosmarijn E.
    De Koker, Stefaan
    Libert, Claude
    Grooten, Johan
    Demeester, Jo
    Gander, Bruno
    De Smedt, Stefaan C.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) : 233 - 239
  • [10] Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology
    Freitas, S
    Merkle, HP
    Gander, B
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) : 313 - 332